NCT05767151Recruiting
Chinese DENOVO PD Registry
The Chinese DENOVO Parkinson's Disease Registry
Source: ClinicalTrials.gov · Last updated 14 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main objective of this longitudinal, multi-center study is to explore the clinical characteristics of PD and confirm biomarkers for PD evolution or progression.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 29 Aug 2022
- Start date
- 1 Jan 2021
- Primary completion date
- 1 Jan 2031
- Lead sponsor
- Xiangya Hospital of Central South University
- Diseases
- Parkinson disease
- NCT number
- NCT05767151
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Jan 2021 to the primary completion date, 1 Jan 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants were treated with antiparkinsonian drugs at baseline
Other illness
- Participants were diagnosed with parkinsonism-syndrome
- Participants with cognitive impairment
Other
- Unable to Written informed consent
Who the study is looking for
- Participants were diagnosed by MDS Clinical Diagnostic Criteria for PD
- Disease duration ≤ 2 years at baseline
- Hoehn-Yahr stage ≤2 at baseline
- The age of PD patients ranges from 30 to 75 years old
- Participants were naive to antiparkinsonian therapy
- Able to Written informed consent
Age in the registry: 30 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xiangya Hospital of Central South University Coordinator of this site? Confirm its status | Changsha | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.